The AI Eye: Veritone's (Nasdaq:VERI) aiWARE Receives FedRAMP Approval and Viome Collaborating with Helomics to Study Cancer with AI

Published: March 25, 2019, 11 a.m.

The AI Eye: Veritone's (Nasdaq:VERI) aiWARE Receives FedRAMP Approval and Viome Collaborating with Helomics to Study Cancer with AI